A quality concern, safety signal, or supply disruption can put life sciences teams under pressure fast. They may need to assess potential patient impact, determine reporting obligations, coordinate with quality and regulatory affairs, and respond to questions from providers, customers, regulators, employees, investors, and the media. Those decisions often have to be made while the facts are still coming into focus.
For in-house legal teams, the challenge is managing urgent, interconnected work without losing sight of the decisions that matter most. Clear escalation paths, close coordination across the business, and enough capacity to handle the surge can help teams respond with greater clarity and control.
Join Axiom and Reservoir Communications Group for a practical discussion on preparing for high-stakes product issues in highly regulated industries. The speakers will explore scenarios such as recalls, field actions, safety matters, and manufacturing or supply disruptions, with life sciences examples, including FDA-related considerations. They will discuss how legal, regulatory, quality, operations, and communications teams can coordinate their response, and how the lessons apply across other regulated sectors.